Prevention of oxLDL uptake leads to decreased atherosclerosis in hematopoietic NPC1-deficient Ldlr-/- mice.

[1]  A. Pandolfi,et al.  Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis. , 2016, Vascular pharmacology.

[2]  A. Nègre-Salvayre,et al.  Oxidative theory of atherosclerosis and antioxidants. , 2016, Biochimie.

[3]  N. Choudhry,et al.  The Burden of Cardiovascular Disease in Low- and Middle-Income Countries: Epidemiology and Management. , 2015, The Canadian journal of cardiology.

[4]  M. Netea,et al.  Bone marrow‐specific caspase‐1/11 deficiency inhibits atherosclerosis development in Ldlr−/− mice , 2015, The FEBS journal.

[5]  S. Choi,et al.  New Drugs for Treating Dyslipidemia: Beyond Statins , 2015, Diabetes & metabolism journal.

[6]  A. Masclee,et al.  Trapping of oxidized LDL in lysosomes of Kupffer cells is a trigger for hepatic inflammation , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[7]  K. Koh,et al.  How to control residual cardiovascular risk despite statin treatment: focusing on HDL-cholesterol. , 2013, International journal of cardiology.

[8]  W. Buurman,et al.  Specific immunization strategies against oxidized low‐density lipoprotein: A novel way to reduce nonalcoholic steatohepatitis in mice , 2012, Hepatology.

[9]  N. Shao,et al.  Oxidized low-density lipoprotein induces secretion of interleukin-1β by macrophages via reactive oxygen species-dependent NLRP3 inflammasome activation. , 2012, Biochemical and biophysical research communications.

[10]  S. Hida,et al.  Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice. , 2012, Biochemical and biophysical research communications.

[11]  M. Hofker,et al.  Internalization of Modified Lipids by CD36 and SR-A Leads to Hepatic Inflammation and Lysosomal Cholesterol Storage in Kupffer Cells , 2012, PloS one.

[12]  J. Gage,et al.  Caspase-1 deficiency decreases atherosclerosis in apolipoprotein E-null mice. , 2012, The Canadian journal of cardiology.

[13]  S. Xanthoulea,et al.  Myeloid IκBα Deficiency Promotes Atherogenesis by Enhancing Leukocyte Recruitment to the Plaques , 2011, PloS one.

[14]  P. Libby,et al.  Progress and challenges in translating the biology of atherosclerosis , 2011, Nature.

[15]  G. Hansson,et al.  The immune system in atherosclerosis , 2011, Nature Immunology.

[16]  L. Joosten,et al.  Oxidized LDL enhances pro-inflammatory responses of alternatively activated M2 macrophages: a crucial role for Krüppel-like factor 2. , 2011, Atherosclerosis.

[17]  Egil Lien,et al.  NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals , 2010, Nature.

[18]  M. Hofker,et al.  Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice. , 2010, Gastroenterology.

[19]  K. Moore,et al.  NLRP3 inflamasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease , 2010, Nature.

[20]  Paul M Ridker,et al.  Inflammation in atherosclerosis: from pathophysiology to practice. , 2009, Journal of the American College of Cardiology.

[21]  J. Tschopp,et al.  T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes , 2009, Nature.

[22]  Joseph L. Goldstein,et al.  Structure of N-Terminal Domain of NPC1 Reveals Distinct Subdomains for Binding and Transfer of Cholesterol , 2009, Cell.

[23]  D. Ory,et al.  Niemann-Pick C1 protects against atherosclerosis in mice via regulation of macrophage intracellular cholesterol trafficking. , 2008, The Journal of clinical investigation.

[24]  Jody C. Ullery,et al.  Lysosomal Cholesterol Accumulation Inhibits Subsequent Hydrolysis of Lipoprotein Cholesteryl Ester , 2008, Microscopy and Microanalysis.

[25]  D. Leake,et al.  Low Density Lipoprotein Undergoes Oxidation Within Lysosomes in Cells , 2007, Circulation research.

[26]  T. V. van Berkel,et al.  Regulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion development , 2006, FEBS letters.

[27]  M. Hofker,et al.  Lipopolysaccharide-induced gene expression in murine macrophages is enhanced by prior exposure to oxLDL Published, JLR Papers in Press, July 13, 2006. , 2006, Journal of Lipid Research.

[28]  Peter Libby,et al.  The immune response in atherosclerosis: a double-edged sword , 2006, Nature Reviews Immunology.

[29]  Jody C. Ullery,et al.  Aggregated LDL and lipid dispersions induce lysosomal cholesteryl ester accumulation in macrophage foam cells Published, JLR Papers in Press, July 16, 2005. DOI 10.1194/jlr.M500059-JLR200 , 2005, Journal of Lipid Research.

[30]  J. Richardson,et al.  Cholesterol accumulation and liver cell death in mice with Niemann‐Pick type C disease , 2005, Hepatology.

[31]  S. Rubin,et al.  The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. , 2004, Diabetes.

[32]  I. Tabas,et al.  Niemann-Pick C heterozygosity confers resistance to lesional necrosis and macrophage apoptosis in murine atherosclerosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[33]  H. Du,et al.  Distinct Endosomal Compartments in Early Trafficking of Low Density Lipoprotein-derived Cholesterol* , 2003, Journal of Biological Chemistry.

[34]  J. Witztum,et al.  Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL , 2003, Nature Medicine.

[35]  P. Yancey,et al.  The Role of Microscopy in Understanding Atherosclerotic Lysosomal Lipid Metabolism , 2003, Microscopy and Microanalysis.

[36]  J. Witztum,et al.  Innate and acquired immunity in atherogenesis , 2002, Nature Medicine.

[37]  P. Yancey,et al.  Lysosomal cholesterol derived from mildly oxidized low density lipoprotein is resistant to efflux. , 2001, Journal of lipid research.

[38]  J. Bonifacino,et al.  Lysosome‐related organelles , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  P. Yancey,et al.  Lysosomal lipid accumulation from oxidized low density lipoprotein is correlated with hypertrophy of the Golgi apparatus and trans-Golgi network. , 1998, Journal of lipid research.

[40]  W. Pavan,et al.  Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. , 1997, Science.

[41]  H. Mandel,et al.  Macrophage uptake of oxidized LDL inhibits lysosomal sphingomyelinase, thus causing the accumulation of unesterified cholesterol-sphingomyelin-rich particles in the lysosomes. A possible role for 7-Ketocholesterol. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[42]  MichaelAviram,et al.  Macrophage Uptake of Oxidized LDL Inhibits Lysosomal Sphingomyelinase, Thus Causing the Accumulation of Unesterified Cholesterol–Sphingomyelin–Rich Particles in the Lysosomes , 1995 .

[43]  W. Jerome,et al.  Early atherogenesis in White Carneau pigeons. II. Ultrastructural and cytochemical observations. , 1985, The American journal of pathology.

[44]  D. Briles,et al.  Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae , 1982, The Journal of experimental medicine.

[45]  Z. Mallat,et al.  Macrophages , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[46]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2015 .

[47]  M. He,et al.  OxLDL-induced IL-1beta secretion promoting foam cells formation was mainly via CD36 mediated ROS production leading to NLRP3 inflammasome activation , 2013, Inflammation Research.

[48]  J. Berliner,et al.  A role for oxidized phospholipids in atherosclerosis. , 2005, The New England journal of medicine.

[49]  E. Dennis,et al.  Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. , 1999, The Journal of clinical investigation.

[50]  D. Steinberg,et al.  Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[51]  C. de Duve.  Lysosomes revisited. , 1983, European journal of biochemistry.